Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use OSENI® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral useInitial U.S. Approval: 2013
Medication labelWhy this: Advisory · dailymed-prescription
OSENI is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Limitations of Use OSENI is not recommended for use in patients with type 1 diabetes mellitus.
- generic_name
- alogliptin and pioglitazone
- product_names
- alogliptin and pioglitazone
- ndc
- 64764-123, 64764-123-03, 64764-123-04, 64764-123-05, 64764-251, 64764-251-03, 64764-251-04, 64764-251-05, 64764-254, 64764-254-03, 64764-254-04, 64764-254-05, 64764-253, 64764-253-03, 64764-253-04, 64764-253-05
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en